Information Library

Results for: Hear From the Experts - Product Development & Commercialization

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Harish Dave Discusses ASH 2011

    December 8, 2011
    Harish Dave discusses the American Society of Hematology annual meeting.

  • Dr. Frank Massam

    May 13, 2011
    Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd.

  • New Healthcare Architecture to Maximize Vaccine Coverage Rates

    April 19, 2011
    Jason Baumgartner discusses the steps required to create a complete healthcare architecture the shift among biopharma toward preventive medicine.

  • Exclusive Report From Scientific American

    November 9, 2010
    In-depth insights on every angle of the changing health landscape - brought to you by Quintiles Get the report today.

  • Healthcare's Future Tools

    November 8, 2010
    Beyond Genomics. The knowledge gained in mapping the genome is producing more tools and new ways of understanding how the human body works. See what's in store in this exclusive report.

  • Podcast: Clinical Development of Cancer Drugs in China

    October 18, 2010
    Hear exclusive interviews with Quintiles's experts, Christopher Ung, Patty James and Harish Dave on their recent participation at the 13th Annual Chinese Society of Clinical Oncology

  • Jeffrey Cummings, M.D.

    September 21, 2010
    Jeffrey Cummings, MD Professor of Neurotherapeutics and Drug Development Cleveland Clinic Lerner College of Medicine Director, Cleveland Clinic Lou Ruvo Center for Brain Health Jeffrey

  • Philip Scheltens, MD

    May 20, 2010
    Prof. Dr. Philip Scheltens, VU Medical Center, Amsterdam Dr Philip Scheltens studied at the VU University Amsterdam, Netherlands

  • Amir Kalali, MD

    May 20, 2010
    Amir Kalali, MD Vice President, Medical and Scientific Services CNS Global Therapeutic Team Leader, Quintiles Amir Kalali, MD, is Vice President, Medical and Scientific Services,

  • Regulatory Landscapes for Future Antidiabetic Drug Development

    May 12, 2010
    In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk.

Page 1 of 3 (28 results)

Subscribe to Email Based on Your Interests

Set preferences